BPA Call HHSN263200400060800B-HHSN27200013

<p>The federal contract award HHSN272201000920P was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Enzo Life Sciences International, Inc., a subsidiary of Enzo Biochem, Inc. The $4,992.50 firm fixed-price purchase order is for unspecified products or services related to the NIAID's acquisitions program. The contract has no set-aside designation and was awarded on August 25, 2010 with a completion date of September 2, 2010.</p>

This federal contract award was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian federal agency, to Enzo Life Sciences, Inc., a for-profit manufacturer of scientific and diagnostic research products. The $8,712.00 firm fixed price purchase order does not have a set-aside designation. The contract supports biomedical and aging research by providing specialized laboratory equipment, supplies, and diagnostic services to federal research institutions...

<p>This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Affymetrix, Inc. for AMBIS # 1660768 KITS. The contract has a ceiling value of $20,335.50 and an ultimate completion date of February 14, 2014. This contract was not set aside for any specific business type. Affymetrix, Inc. is a for-profit manufacturer of goods and was the prime contractor for this award.</p>

This $9,045.00 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Research And Diagnostic Systems, Inc. (R&amp;D Systems), a manufacturer and supplier of research reagents and instruments. The contract is for the delivery of KIFUNENSINE 10MG, which is a research reagent likely used to support biomedical investigations related to infectious diseases, cancer, and other health...

This is a $8,835.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to E G F Import &amp; Export LLC, a minority-owned, small disadvantaged business. The contract is for the delivery of 50 units of the product &quot;LENDNAFECT 1ML (LIPOD293), CAT# 50-5099-10&quot; at a unit price of $176.00. The award date was April 21, 2016, and the ultimate completion date is...

<p>The federal contract award HHSN272201601160P was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to ABI Scientific Inc. for the product KIFUNENSINE. The $11,280.00 firm fixed price purchase order has an ultimate completion date of August 26, 2016. This contract was set aside for a small business, and ABI Scientific Inc. is a minority-owned, for-profit Asian-Pacific American organization.</p>

This is a firm fixed price BPA Call contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to the prime contractor GE Healthcare Bio-Sciences (AMBIS #1544983). The contract, with a ceiling value of $17,660.00, was awarded on March 4, 2011 and has an ultimate completion date of February 28, 2012. This contract is not associated with a set-aside designation. The contract was awarded to Domestic Awardees...

This federal contract award is for the procurement of the Elongase Enzyme Mix 500 RXN, Catalog # 10480028, by the National Institute of Allergy and Infectious Diseases (NIAID) for a ceiling value of $5,939.50. The contract was awarded to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, under a Blanket Purchase Agreement (BPA) call with a firm fixed price. The award did not utilize any set-aside designations. This contract supports NIAID's biomedical research initiatives...

<p>This $23,991.00 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Protein Biosolutions Inc. on May 8, 2014. The contract is for AMBIS # 1678920 SEQUENCING services, with a period of performance ending on June 20, 2014. The contract was not set aside for any specific business type.</p>

This is a firm fixed-price BPA call awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract, valued at $10,200.00, is to provide enzymes with a performance period through April 30, 2024. Life Technologies has been awarded multiple Indefinite Delivery Vehicles (IDVs) with NIH,...